These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15067336)

  • 1. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K; Kaminski R; Legat M; Kopec M; Nowis D; Skierski JS; Koronkiewicz M; Jakóbisiak M; Golab J
    Int J Oncol; 2004 May; 24(5):1149-57. PubMed ID: 15067336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of retinoid Ro 40-8757 on human cancer cell lines in vitro].
    Lu J; Song JD
    Ai Zheng; 2002 Oct; 21(10):1051-6. PubMed ID: 12508641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo.
    Issat T; Nowis D; Legat M; Makowski M; Klejman MP; Urbanski J; Skierski J; Koronkiewicz M; Stoklosa T; Brzezinska A; Bil J; Gietka J; Jakóbisiak M; Golab J
    Int J Oncol; 2007 Jun; 30(6):1413-25. PubMed ID: 17487362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine.
    Malíková J; Zdarilová A; Hlobilková A; Ulrichová J
    Cell Biol Toxicol; 2006 Nov; 22(6):439-53. PubMed ID: 16964588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
    Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
    Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds.
    Wang YA; Johnson SK; Brown BL; Dobson PR
    Oncol Rep; 2009 Feb; 21(2):437-42. PubMed ID: 19148520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
    Ravizza R; Gariboldi MB; Molteni R; Monti E
    Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
    Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells.
    Mimnaugh EG; Monti E; Sebers S; Stetler-Stevenson M; Sinha BK
    Oncol Res; 1992; 4(10):401-12. PubMed ID: 1292755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145.
    Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H
    Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
    Lu HQ; Zheng J
    Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
    Huang Y; Horvath CM; Waxman S
    Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.